SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments
.png)
Brett Wall, EVP and President of Medtronic’s Neuroscience Portfolio, discusses changes and opportunities...
As in-person meetings start to ramp up in 2021, SmartTRAK identifies the latest research, technologies a...
RapidAI President and CEO Don Listwin discusses how advances in AI-based imaging, workflow and products ...
In an interview with SmartTRAK, André Mercanzini, founder and CEO of Aleva Neurotherapeutics, discusses ...
Despite a resurgence in COVID-19 that impacted procedure volumes early in Q121, the SCS Market’s climb t...
Dan Volz, President of Medtronic Neurovascular, discusses what’s next for Medtronic Neurovascular in an ...
Aure Bruneau, CEO of Stimwave, discusses his vision for the Company and taking peripheral nerve stimulat...
SmartTRAK is pleased to announce the addition of the Deep Brain Stimulation (DBS) module to our business...
While US SCS revenues were almost back to pre-COVID levels in Q320, rising COVID case rates put the brak...
In an interview with SmartTRAK, Keith Boettiger, VP of Abbott Neuromodulation, discusses the Company’s n...
Login